• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Targeting inflammasome/IL-1 pathways for cancer immunotherapy.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Targeting inflammasome/IL-1 pathways for cancer immunotherapy.

Targeting inflammasome/IL-1 pathways for cancer immunotherapy. Sci Rep. 2016 10 27; 6:36107.

View in: PubMed

subject areas
  • Animals
  • Breast Neoplasms
  • Caspase 1
  • Cell Line, Tumor
  • Disease Models, Animal
  • Female
  • Humans
  • Immunotherapy
  • Inflammasomes
  • Interleukin-1beta
  • Lung Neoplasms
  • Macrophages
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred NOD
  • Mice, Knockout
  • Myeloid-Derived Suppressor Cells
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • NLR Proteins
  • Receptors, Interleukin-1
  • Signal Transduction

authors with profiles
  • Zihai Li
  • Beichu Guo
  • Bei Liu